Announcement on Resignation of General Manager
Filed with SSE · · 1 page · Chinese
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix
Earlier from Tianjin Pharmaceutical Da Ren Tang
- Announcement on Adding Extraordinary Proposal to the 3rd Extraordinary General Meeting in 2024
- Announcement on Convening the Q3 2024 Performance Briefing
- Announcement on Resignation and By-election of Supervisor
- Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
- Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2024
Later from Tianjin Pharmaceutical Da Ren Tang
- Announcement on Unlocking and Listing of Restricted Shares for the 3rd Restricted Stock Trading Period of the 2019 A-Share Restricted Stock Plan
- Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2024
- Announcement on the Completion of Capital Increase for Jinyao Pacific Pharmaceutical Co., Ltd. and Related Party Transactions
- Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
- Announcement on the Company Completing Transfer of 13% Equity of Tianjin TSKF Pharmaceutical Co., Ltd. and Related Party Transaction
Follow Tianjin Pharmaceutical Da Ren Tang into a list and get an email when it puts out news.
Follow Tianjin Pharmaceutical Da Ren Tang